Technology Solutions

Horizon Discovery enters Chinese Clinical Diagnostics Market

Monday, November 21, 2016

Horizon Discovery Group, a leader in the application of gene editing technologies, has entered into partnerships with three leading Chinese diagnostic kit developers. Under the terms of the agreements, Horizon will provide HDx Reference Standards for novel Next Generation Sequencing (NGS) assay development, clinical trials, and ultimately for inclusion as in-kit controls under Original Equipment Manufacturer (OEM) agreements.

[Read More]

Medidata introduces eConnect Partner Program

Monday, November 21, 2016

Medidata, a global provider of cloud-based solutions and data analytics for clinical research, has launched the Medidata eConnect Partner Program. The collaborative initiative will enable the seamless integration of healthcare data—from electronic health records (EHRs), electronic medical records (EMRs), and clinical trial electronic source data (eSource) systems—with the Medidata Clinical Cloud, a platform powering clinical trials for nearly 800 life sciences organizations worldwide.

[Read More]

Bracket acquires CLINapps

Friday, November 18, 2016

Bracket, a clinical trial technology and specialty services provider, has announced the strategic acquisition of CLINapps, an international software development and consulting firm that offers a comprehensive supply chain management product suite, designed to meet the unique requirements of biopharmaceuticals management.

[Read More]

AHA, Amazon launch cloud-based precision medicine data marketplace

Tuesday, November 15, 2016

The American Heart Association (AHA) announced a milestone in its strategic collaboration with Amazon Web Services (AWS)—the launch of a global, secure cloud-based data marketplace that will help revolutionize how researchers and clinicians come together as one community to access and analyze rich and diverse data to accelerate solutions for cardiovascular diseases—the No. 1 cause of death worldwide. 

[Read More]

TARGET PharmaSolutions, Bristol-Myers Squibb partner on real world data platform

Tuesday, November 15, 2016

TARGET PharmaSolutions, a clinical data company focused on real world evidence, has announced two new collaborations with Bristol-Myers Squibb to advance the understanding of treatment patterns in nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC). The TARGET model provides pharmaceutical and biotechnology partners access to a robust disease state registry that is also linked to a biorepository and patient reported outcomes, providing unique data and insights compared to typical patient registries.

[Read More]